Fluorine in PDB 7nr5: Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2

Enzymatic activity of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2

All present enzymatic activity of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2:
2.7.11.24;

Protein crystallography data

The structure of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 7nr5 was solved by M.O'reilly, A.Cleasby, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.07 / 1.77
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 48.903, 70.937, 60.445, 90, 110.17, 90
R / Rfree (%) 17.4 / 22.3

Other elements in 7nr5:

The structure of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 (pdb code 7nr5). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 7nr5:

Fluorine binding site 1 out of 1 in 7nr5

Go back to Fluorine Binding Sites List in 7nr5
Fluorine binding site 1 out of 1 in the Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F405

b:27.3
occ:1.00
 F6 A:UOH405 0.0 27.3 1.0
C5 A:UOH405 1.4 27.4 1.0
C4 A:UOH405 2.3 27.5 1.0
C7 A:UOH405 2.4 26.4 1.0
H47 A:UOH405 2.5 27.6 1.0
H48 A:UOH405 2.5 26.4 1.0
OG1 A:THR68 3.0 23.5 1.0
O A:TYR64 3.1 24.3 1.0
CB A:TYR64 3.3 32.3 1.0
CA A:TYR64 3.5 30.1 1.0
CG2 A:ILE56 3.5 27.8 1.0
C A:TYR64 3.6 26.8 1.0
C3 A:UOH405 3.6 28.3 1.0
C8 A:UOH405 3.6 26.7 1.0
CB A:PRO58 3.8 28.3 1.0
CG A:TYR64 3.8 35.5 1.0
C9 A:UOH405 4.1 27.3 1.0
CD2 A:TYR64 4.1 37.8 1.0
CB A:THR68 4.4 21.1 1.0
N A:THR68 4.5 22.7 1.0
CB A:ARG67 4.6 24.5 1.0
CA A:PRO58 4.6 27.0 1.0
CD1 A:TYR64 4.6 37.1 1.0
O A:TYR36 4.7 33.3 1.0
H44 A:UOH405 4.7 31.4 1.0
CG A:PRO58 4.8 29.1 1.0
O2 A:UOH405 4.8 30.3 1.0
N A:CYS65 4.8 25.8 1.0
H46 A:UOH405 4.8 31.3 1.0
CA A:THR68 4.9 21.3 1.0
C10 A:UOH405 4.9 25.0 1.0
H51 A:UOH405 4.9 25.1 1.0
N A:TYR64 4.9 30.6 1.0
CB A:ILE56 4.9 27.2 1.0
H42 A:UOH405 4.9 25.0 1.0
O A:HOH503 5.0 38.3 1.0

Reference:

T.D.Heightman, V.Berdini, L.Bevan, I.M.Buck, M.G.Carr, A.Courtin, J.E.Coyle, J.E.H.Day, C.East, L.Fazal, C.M.Griffiths-Jones, S.Howard, J.Kucia-Tran, V.Martins, S.Muench, J.M.Munck, D.Norton, M.O'reilly, N.Palmer, P.Pathuri, T.M.Peakman, M.Reader, D.C.Rees, S.J.Rich, A.Shah, N.G.Wallis, H.Walton, N.E.Wilsher, A.J.Woolford, M.Cooke, D.Cousin, S.Onions, J.Shannon, J.Watts, C.W.Murray. Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J.Med.Chem. V. 64 12286 2021.
ISSN: ISSN 0022-2623
PubMed: 34387469
DOI: 10.1021/ACS.JMEDCHEM.1C00905
Page generated: Fri Aug 2 10:12:15 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy